WELL Health Technologies Corp (WELL – Research Report) has received a rating update from a Wall Street analyst today. Analyst David Kwan from TD Securities reiterated a Buy rating, with a C$8.00 price target.
Kwan has an average return of 76.3% when recommending WELL Health Technologies Corp.
According to TipRanks.com, Kwan is ranked #524 out of 8631 analysts.
Currently, the analyst consensus on WELL Health Technologies Corp is a Strong Buy with an average price target of C$8.41, which is a 92.0% upside from current levels. In a report issued on November 9, Scotiabank also maintained a Buy rating on the stock with a C$6.50 price target.
The company has a one-year high of C$5.94 and a one-year low of C$2.56. Currently, WELL Health Technologies Corp has an average volume of 672.3K.
WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: Clinical services, Digital services, and others. It also engages in the Electronic Medical Records business that supports the digitization of clinics. Its objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health.
The company’s shares closed last Wednesday at C$3.85.
Read More on TSE:WELL:
- WELL Health Reports Record Results for Q3-2023, Raises Guidance for Balance of 2023 and Provides Guidance of Over $900 Million in Revenue for 2024
- WELL Upcoming Earnings Report: What to Expect?
- WELL Health’s Cycura Announces Two Tuck-In Acquisitions to Enhance Patient Data Protection and Appoints New Management
- WELL Health Completes Clinic Acquisition and Investment Transactions with HEALWELL AI Inc. (formerly MCI Onehealth), and Forms Strategic Alliance Focused on Developing AI Enabled Disease Detection and Preventative Care Tools for Care Providers
